Pharmacists in Mount Pocono, Pennsylvania


12 Pharmacists found in Mount Pocono
female pharmacist

Dr. Amanda Louise Nowakowski, PHARMD


Pharmacist
601 Route 940, Mount Pocono, PA 18344
570-839-9131    

male pharmacist

Mr. Kenneth Michael Czar, RPH


Pharmacist
601 Route 940, Mount Pocono, PA 18344
570-839-9131     570-839-1233

female pharmacist

Miss Kimberly Ann Martini, RPH


Pharmacist
89 Sr 940 (route 940 & 611), Mount Pocono, PA 18344
570-839-7682     570-839-5347



female pharmacist

Lauren Englert


Pharmacist
126 Market Way, Mount Pocono, PA 18344
570-895-5055     570-895-5056

female pharmacist

Luann Domenico, R.PH.


Pharmacist
126 Market Way, Mount Pocono, PA 18344
570-895-5055    

female pharmacist

Dr. Makenzie Elizabeth Batt


Pharmacist
3382 Route 940, Mount Pocono, PA 18344
570-839-3797    

female pharmacist

Mrs. Paula Ann Keller


Pharmacist
3430 Route 940 Ste 102, Mount Pocono, PA 18344
570-839-5340    

female pharmacist

Rachelle Wohlers


Pharmacist
103 Route 940, Mount Pocono, PA 18344
570-839-3797     570-839-3172

male pharmacist

Dr. Robert Alan Panzik, PHARMD RPH


Pharmacist
500 Route 940, Mount Pocono, PA 18344
570-895-4781     570-895-4787

male pharmacist

Stephen Flyte


Pharmacist
3430 Route 940, Suite 102, Mount Pocono, PA 18344
570-839-5340    

female pharmacist

Susan Franchetti


Pharmacist
3236 Route 940 Suite 116, Mount Pocono, PA 18344
570-839-6240    

female pharmacist

Tricia Stefanick, PHARM D


Pharmacist
500 Route 940, Mount Pocono, PA 18344
570-895-4781     570-895-4787


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.